Ocugen has tested support twice at the $7.80-$8.00 range. There was a sharp sell-off after WHO approval was announced, but it's likely that approval added $1-$2 to the consolidating price. Two important catalysts are on the horizon: Potential Canadian approval and USA pediatric EUA. Ocugen will resume a strong uptrend if either of these comes through....
I have been following Ocugen for quite some time now and decided to reassess with the recent run up on 10/26/2021.
Using trendlines, fibonnaci and pitchforks it seems that the downtrend will finally break with todays confirmation. (CHECKOUT THE MOVING AVERAGES AS WELLL)
With news of COVAXIN getting WHO approval on NOV 3, I speculate that this will run parabolic...
We arribe to the final countdown and go up... If the news are good the movement will be bullish.
I show you my prediction lines:
Blue -> Hard Resistance that if overcome will become hard support.
Red -> Resistance that if overcome will become support.
Orange -> Bearish trend that we broke days ago and that we do not want to see any more.
Good luck to all!
OCGN Ocugen partnered with Bharat Biotech for Covaxin, the first COVID vaccine developed in India to receive emergency authorization.
With the COVID significant rise in cases, hospitalizations and deaths over the last two weeks, vaccines producers are rising once again.
My short term Price Target is 10.30usd
OCGN kind of treading water for now. I think what we need to see are some rock-solid results from COVAXIN, which this rolling submission could be helpful in identifying. The Phase 3 results were interesting. With more warnings coming out about the current SOC EAU vaccines, another option might not be "too late" at this point. But a lot will clearly come down to...
#Ucugen breaking out of the ascending triangle.
- Trend continuation to 20.00 USD expected!
- Ocugen Inc. is a biopharmaceutical company focused on the development, development and commercialization therapies for eye diseases.
- Ocugen is developing a vaccine against COVID-19.
- Number of employees: 15 people.
All of OCUGEN Investors wait of FDA aproval, or any anouncement that talk about OCGN.
This week seems to any thing can happen.
I hope that give us good news very early!
I publish this chart to get an idea of how the stock behaves, I am by no means an expert. I just hope that what I think will happen if the FDA talks about OCGN.
It is pretty clear from our analysis that OCUGEN loves triangles and channels!
-It first started its uptrend with the left-most small symmetrical triangle and jumped up from there.
-Then it formed the 2nd symmetrical and again launched the rocket.
-After the 2nd symmetrical, it formed a bearish channel. It then fell tremendously and has risen back up to form an...
I am a newbie, and I publish this idea for me, I share it so that if any expert can help me and correct it, he can do it.
On Monday it will finish forming a bullish pennant that by volume indicates that the share will be bullish.
It is very likely that all this movement will be accompanied by the crossing of the M20 to the M50 and then both will pass the M200as...